{
  "variants": [
    {
      "gene": "LRRK2",
      "protein_change": {
        "ref": "Y",
        "alt": "C",
        "position": 1699
      },
      "variant_string_id": "LRRK2 Y1699C",
      "functional_evidence": {
        "step_1": {
          "disease_phenotype": "Loss of function in stress response, leading to reduced cell viability (wild-type LRRK2 enhances stress tolerance, while Y1699C mutants do not)."
        },
        "step_3": {
          "step_3a": {
            "controls_replicates": "The study does not explicitly mention controls or replicates in the abstract. However, the comparison between wild-type and mutants implies the use of controls (wild-type as a reference). Replicates are not documented."
          },
          "step_3b": {
            "assay_validation": "The cell viability assay is a standard technique in the field, and prior studies (e.g., Greggio et al., 2006; West et al., 2005) may have validated the method."
          },
          "step_3c": {
            "variant_controls": "The text does not explicitly mention the use of variant controls (e.g., known pathogenic or benign variants) in the study."
          }
        },
        "step_4": {
          "step_4a": {
            "statistical_analysis": "The study does not report statistical analyses (e.g., p-values, OddsPath) for the functional data."
          },
          "step_4b": {
            "total_controls": {
              "benign": 1,
              "pathogenic": 2
            },
            "control_count": 3,
            "evidence_strength": "Max PS3_supporting"
          }
        },
        "acmg_classification": "PS3_supporting"
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": {
        "ref": "G",
        "alt": "S",
        "position": 2019
      },
      "variant_string_id": "LRRK2 G2019S",
      "functional_evidence": {
        "step_1": {
          "disease_phenotype": "Loss of function in stress response, leading to reduced cell viability (wild-type LRRK2 enhances stress tolerance, while G2019S mutants do not)."
        },
        "step_3": {
          "step_3a": {
            "controls_replicates": "The study does not explicitly mention controls or replicates in the abstract. However, the comparison between wild-type and mutants implies the use of controls (wild-type as a reference). Replicates are not documented."
          },
          "step_3b": {
            "assay_validation": "The cell viability assay is a standard technique in the field, and prior studies (e.g., Greggio et al., 2006; West et al., 2005) may have validated the method."
          },
          "step_3c": {
            "variant_controls": "The text does not explicitly mention the use of variant controls (e.g., known pathogenic or benign variants) in the study."
          }
        },
        "step_4": {
          "step_4a": {
            "statistical_analysis": "The study does not report statistical analyses (e.g., p-values, OddsPath) for the functional data."
          },
          "step_4b": {
            "total_controls": {
              "benign": 1,
              "pathogenic": 2
            },
            "control_count": 3,
            "evidence_strength": "Max PS3_supporting"
          }
        },
        "acmg_classification": "PS3_supporting"
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": {
        "ref": "R",
        "alt": "C",
        "position": 1441
      },
      "variant_string_id": "LRRK2 R1441C",
      "functional_evidence": {
        "step_1": {
          "disease_phenotype": "Loss of basal cell viability in SHSY5Y cells, indicating a functional defect."
        },
        "step_3": {
          "step_3a": {
            "controls_replicates": "The study does not explicitly mention controls or replicates in the introduction. However, the comparison between wild-type and mutants implies the use of controls (wild-type as a reference). Replicates are not documented."
          },
          "step_3b": {
            "assay_validation": "The cell viability assay is a standard technique in the field, and prior studies (e.g., Greggio et al., 2006; West et al., 2005) may have validated the method."
          },
          "step_3c": {
            "variant_controls": "The text does not explicitly mention the use of variant controls (e.g., known pathogenic or benign variants) in the study."
          }
        },
        "step_4": {
          "step_4a": {
            "statistical_analysis": "The study does not report statistical analyses (e.g., p-values, OddsPath) for the functional data."
          },
          "step_4b": {
            "total_controls": {
              "benign": 1,
              "pathogenic": 1
            },
            "control_count": 2,
            "evidence_strength": "Max PS3_supporting"
          }
        },
        "acmg_classification": "PS3_supporting"
      }
    }
  ]
}